 SeaStar Medical Inc, a medical tech corporation focusing on the development of extracorporeal therapy treatments to reduce the symptoms of vital organ inflammation, is merging with LMF Acquisition Opportunities Inc NASDAQ: LMAO, a publicly trading special purpose acquisition business, to get a NASDAQ trading listing. The merger agreement is expected to give SeaStar access to the capital market. 